Share Name Share Symbol Market Type Share ISIN Share Description
Omega Dia LSE:ODX London Ordinary Share GB00B1VCP282 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 20.00p 19.50p 20.50p 20.00p 20.00p 20.00p 0 07:53:43
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 14.2 0.7 1.1 18.2 25.38

Omega Diagnostics Share Discussion Threads

Showing 1926 to 1949 of 1950 messages
Chat Pages: 78  77  76  75  74  73  72  71  70  69  68  67  Older
DateSubjectAuthorDiscuss
21/8/2017
11:03
Well we shall see barrywhit, I AM AN OPTIMIST/REALIST by nature so still feeling chipper 😛 For no particular reason I have provided an updated major holdings table in Omega although it could well prove to be inaccurate as unsure whether some of the institutions participated in the recent placing/fundraising. TOTAL NUMBER OF SHARES NOW IN ISSUE 126,884,060 Omega Major Shareholdings as at 21 August 2017 Number % NAME Richard Edgar Sneller 16,409,157 12.93 Legal & General Investment Management Ltd 15,851,031 12.49 Liontrust Investment Partners 8,711,494 6.87 Octopus Invetments Limited 6,682,730 5.27 Hargreaves Lansdown Stockbrokers 6,328,227 4.99 Unicorn Asset Management 4,226,750 3.36 SG Private Banking 4,264,281 3.36 David Eric Evans (Chairman) 4,154,745 3.27 Moebus Equity Partners LLP 3,999,950 3.15 Charles Stanley Stockbrokers 3,682,127 2.90 Andrew William Shepherd (Chief Exec) 2,829,291 2.22 Kieron Harbinson (Finance Director) 481,617 0.38 Colin King (Chief Operating Officer) 277,777 0.22 Jagdeep Grewal (Sales Director) 153,246 0.12
hyperboreus
21/8/2017
10:08
Hyperboreus, Keepthefaith, not easy sometimes with this share, looks like someone has given up waiting over the last week......
barrywhit
18/8/2017
11:02
Another exciting job opportunity for someone 🤓 Assay Development Scientist For more information or to submit your CV contact odl@omegadiagnostics.co.uk Https://www.facebook.com/omegadiagnostics It will come good eventually #keepthefaith 👍
hyperboreus
14/8/2017
13:06
Taken from ODX facebook page a short time ago: Omega Diagnostics is looking for a number of enthusiastic individuals to join our team. We are hiring for the following positions: Procurement Scientist (2) Planner Regulatory Affairs Associate (2) Clinical Regulatory Affairs Manager (12 month contract) These roles will be based at our offices in either Alva, Scotland or Ely, England, or both. If you are interested in any of the above positions or would like some further information, please email odl@omegadiagnostics.co.uk
hyperboreus
14/8/2017
10:14
Thanks for the explanation . :-)DbD
death by donut
14/8/2017
08:16
In the recent trading update (and financial results), the company notified the market of some issues with the self-test version of food detective. They are working on an agreed timetable to implement corrective actions with the regulatory body, but naturally if they fail to meet that timetable then their CE registration is at risk of being temporarily suspended. Having worked with the same body myself, I know them to be fairly flexible. As long as you are working pro-actively towards a solution they are generally satisfied. They do have the power to suspend CE registration and whilst such events rarely occur, it is sensible for the BoD to have notified the market. If the issues had been serious, then CE registration would have already been suspended, so my take on the situation is that the risk is relatively low. Given the many new product lines being launched: Visitect CD4/Malaria RDT kits and Allersys array - together with the ramp-up in sales of Food Print to the Americas/China I would say that there is overall more good news in the pipeline than bad... I suspect jeevsje, like the cobra, has been disappointed in the rapidly vanishing opportunity to profit from the recent weakness.
longshanks
14/8/2017
07:46
Food detective CE issues update imminent in the coming days. Rising to suck people in?
jeevsje
11/8/2017
15:46
A few Friday afternoon sellers, some news from the company would be appreciated, how is the IDH deal going??
barrywhit
10/8/2017
14:46
No problem, I just get tired of small private investors whingeing about institutions getting preferential treatment when placings are announced but, speaking in very general terms, when they get the opportunity they don't step up to the plate. Anyway let's move on. I'm looking forward to developments here.
columbarius
10/8/2017
14:22
columbarius - Re: Your comments on my investment strategy (post 136 above) - Fair comment to an extent. I had in fact added a few days before the offer was announced and probably felt a bit peeved as the immediately available cash had been spent. I didn't feel inclined to make the necessary adjustments to free up some more. On later reflection, with the dent in the share price appearing to have run its course being stable at the 18p level I put in a cheeky limit order which happily got filled - possibly the mm trying a shake before the take-off he expected was coming(?). Fortuitous timing and anyway I expect we are all happier with progress today which leaves all of my buys nicely in profit.
boadicea
10/8/2017
12:14
Good luck with your investment.
columbarius
10/8/2017
12:10
Thanks for the correction columbarius.
verger
10/8/2017
10:55
Having said that, numerous companies on AIM exist to enrich directors at the expense of fools. This isn't one of them.
columbarius
10/8/2017
10:52
Of course the placing was fully subscribed. It's only the open offer that wasn't fully taken up by private investors and I wouldn't read anything into that at all as AIM companies attract more than their fair share of mickey mouse investors.
columbarius
10/8/2017
10:04
Gone through now. barrywhit, it makes a lot of sense to be patient with ODX. It's recent funding exercise was a vote of confidence, at least from the company, of what lies ahead. I was surprised the placing was not fully subscribed. I have bought more since only because my funds were not available at the time.
verger
10/8/2017
09:37
Verger, I believe most holding are here for the medium to long term, hence not many sellers "at present".....
barrywhit
10/8/2017
08:31
50,000 purchase still not showing.
verger
10/8/2017
08:27
From my purchase this morning I get the impression that despite the big recent placing there are not many sellers about. Good news.
verger
09/8/2017
15:58
It does show confidence longshanks as it adds at least £200k pa to the existing wage bill....
barrywhit
09/8/2017
15:23
9 new employees represents a 5% increase in the workforce. Significant certainly but not necessarily a weather vane on the commercialisation success (or lack of) of the new product initiatives: too early yet for that I would expect.It is though a strong indication of management confidence and shows why they were so keen to raise cash.Good to see the price perking up. The cobra doesn't appear to have struck yet. Looks to me like it might have lost the opportunity it was seeking.
longshanks
09/8/2017
14:08
Pretty big expansion I would suggest given the current size of the company. It means they are expecting a substantial increase in workload to include their expanding sales and product range with Visitect CD4 being the jewel in the crown "no comparable product on the market"
dibs61
09/8/2017
11:26
Good to see the company are moving forward fairly quickly......
barrywhit
09/8/2017
11:03
Expanding on Dibs61 comment taken from their facebook page, all very positive stuff: Omega Diagnostics Group PLC WE'RE HIRING. We are expanding our Quality Assurance and Regulatory Affairs functions in our two major UK companies, Omega Diagnostics in Alva, Scotland and Genesis Diagnostics in Ely, England. The following Quality Assurance roles have become available: Validation Manager Product Quality Manager Quality Systems Manager Product Quality Associates (2) Quality Systems Associates (2) Document Controller Validation Assistant Please email your interest along with you CV to odl@omegadiagnostics.co.uk. Closing date for all applications is 25 August 2017. Keep an eye out for the Regulatory Affairs roles which will be announced shortly.
hyperboreus
09/8/2017
10:55
Company have announced they are creating 9 new hire positions in quality assurance area - looks like infectious diseases LOB to me. Plus more to be announced in regulatory affairs shortly. Clear indication of expansion. Indicating CD4 commercialisation getting ever closer?
dibs61
Chat Pages: 78  77  76  75  74  73  72  71  70  69  68  67  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20170822 07:25:28